Proveris Scientific

Hudson, United States Founded: 1995 • Age: 31 yrs Acquired By Investindustrial
Provides testing equipment and services for nasal sprays and inhalers worldwide.

About Proveris Scientific

Proveris Scientific is a Healthcare company based in Hudson (United States) founded in 1995, and was acquired by Investindustrial in January 2026. It provides testing equipment and services for nasal sprays and inhalers worldwide. It operates on a B2B model. Proveris Scientific offers products and services including SprayVIEW Measurement Systems, Vereo Actuators, and Viota Software. Its focus areas include Pharmaceutical Tech, Drug Testing, Aerosol Analysis and Medical Devices. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.

Company details

Proveris Scientific specializes in developing advanced testing instruments and laboratory services for orally inhaled and nasal drug products. They focus on spray characterization, automated actuation, and software solutions to support pharmaceutical development from early RD to manufacturing. Based in Hudson, Massachusetts, USA, they serve global clients in the healthcare industry with precision testing and validation services.

  • Headquarters Hudson, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website proveris.com
  • Social LinkedIn X
  • Acquired by Investindustrial (Jan 2026)
Operational Areas
Key Metrics

Products & Services of Proveris Scientific

Proveris Scientific offers a comprehensive portfolio of products and services, including SprayVIEW Measurement Systems, Vereo Actuators, and Viota Software.

SprayVIEW Measurement Systems
Testing Equipment

System for analyzing spray characteristics in pharmaceutical applications.

Vereo Actuators
Automated Devices

Tools for precise actuation in nasal and oral drug testing.

Viota Software
Software Solutions

Platform for managing and analyzing testing data in drug development.

Investors in Proveris Scientific

Proveris Scientific has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Investindustrial.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Buyouts are targeted by this private equity investment firm.
investindustrial.comShanghai, China
Premium access

Investor details for Proveris Scientific

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Proveris Scientific

15 people are tracked at Proveris Scientific (10 in leadership, 5 in team).

NameRoleGroup
Maria Smith
Director, Application And Business DevelopmentLeadership
Joanne Mather
Senior Director Of MarketingLeadership
Dino J. Farina
Founder & CEOLeadership
Julie Peddle
Executive Assistant To The PresidentLeadership
Stephen E. Houlihan
Financial DirectorLeadership
Chip Leveille
PresidentLeadership
Eric Uffman
National Sales DirectorLeadership
Ben Okorodudu
VP SalesLeadership
Deborah Jones
Sales Director- EMEA And IndiaLeadership
John Grega
Director Of Quality AssuranceLeadership
Grant Thurston
Product ManagerTeam
Ali Alkhatatbih
Software EngineerTeam
Teresa Carroll
Marketing Communications ManagerTeam
Sandor Goldstein
Inside Sales Manager / Customer SuccessTeam
Lynn Jordan
Senior Applications ManagerTeam
Premium access

Complete people profiles for Proveris Scientific

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Proveris Scientific

2 dated milestones of Proveris Scientific across 31 years, from founding to its latest funding, stage changes and deals.

  1. Founded Proveris Scientific is founded.
  2. Exit Acquired by Investindustrial.

Competitors of Proveris Scientific

Proveris Scientific has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
celgene.com1986Summit, United States$45M4,891
Therapies for cancer and inflammatory diseases are developed.
syneoshealth.com1984Raleigh, United States29,395
CRO clinical development services are provided by Syneos Health.
wcct.com1998Cypress, United States$17M229
Full-service CRO expertise in influenza and oncology research is offered.
Premium access

Detailed competitors of Proveris Scientific

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Proveris Scientific

The website of Proveris Scientific (proveris.com) receives about 4.6K visits a month.

  • Monthly visits
    4.6K

    ▼ 28.1% vs previous month

Top companies in Toxicology

3 companies that operate in the same segment as Proveris Scientific (Toxicology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutic solutions for food allergies are developed via antibody platforms.
2019San Francisco, California, United StatesUSD 75 M
Therapeutics for substance use disorders, including opioid-related conditions, are developed.
2020Oakland, California, United StatesUSD 70 M
Drug delivery solutions via single-walled carbon nanotubes are offered.
2008Houston, Texas, United StatesUSD 2.5 MUSD 5.07 M9
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Proveris Scientific

Premium access

Complete news archive for Proveris Scientific

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Proveris Scientific

Proveris Scientific was founded in 1995.

Proveris Scientific is headquartered in Hudson, United States.

Proveris Scientific specializes in developing advanced testing instruments and laboratory services for orally inhaled and nasal drug products. They focus on spray characterization, automated actuation, and software solutions to support pharmaceutical development from early RD to manufacturing. Based in Hudson, Massachusetts, USA, they serve global clients in the healthcare industry with precision testing and validation services.

Proveris Scientific's top competitors include Syneos Health, Medelis WCCT Global and Celgene.

Proveris Scientific offers SprayVIEW Measurement Systems, Vereo Actuators, and Viota Software.

Proveris Scientific has 1 investor. Key investors include Investindustrial.

Yes. Proveris Scientific was acquired by Investindustrial in January 2026.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available